G4Derm
Commercial- Indications
- Wound care, Surgical reconstruction
Company intelligence / Profile preview
Gel4Med
Allston, Massachusetts, United Statesgelformed.com ↗
- Ownership
- Private
- Employees
- ~14
- Development stage
- Commercial
01
Overview
Gel4Med develops programmable biomaterial platforms focused on antimicrobial tissue-scaffolding matrices that promote tissue regeneration and prevent bacterial colonization. Their lead products, G4Derm and G4Derm Plus, are biosynthetic flowable wound matrices designed to address unmet needs in chronic and acute wound management. The company’s technology enables customizable, non-toxic, biodegradable scaffolds with broad application potential across regenerative medicine. G4Derm Plus was named a Top Innovation in Podiatry by Podiatry Today in July 2024. Backers include Breakout Labs (Peter Thiel), NIH, DoD, NSF, MLSC, and Mass Ventures.
- Therapeutic areas
- OtherDermatologyOphthalmology
- Modalities
- Biomaterials (biosynthetic matrices)Smart Materials Platform (amino-acid derived polypeptide hydrogels)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Gel4Med.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gel4Med.